Exploring dosage of sotalol on arrhythmia
Hong Zhong-li
Abstract
Hong Zhong-li
Abstract
Objective: To detect the efficacy and optimal dosage of sotalol on arrhythmia. Methods: 53 patients with non-myocardial infarction receiving sotalol with different string-does, were evaluated by clinic and 24-hour Holier monitoring. Results: (1) In all 53 patients, 39 cases were efficiency, the total effective rate was 73.58%. (2)In 39 efficacy cases, the average does was 93.57mg/d. (3)After oral low-does sotalol, QTc interval increased from (0.39±0.03) s to (0.41±0.03) s (0.01P0.05), HR decreased from (79.39±13.85) beats/min to (64.11 ± 8.19) beats/min(P0.01) But BP had no significant difference. (4) There were 9 cases had side effects, but all were alleviated by decreasing the dosage. No torsade de pointes. Conclusion: Sotalol was efficiency in treatment of supraventricular or ventricular arrhythmia.Its average efficient dose was low and its side effect was seldom. So it would become a better antiarrhythmic drug in future.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To detect the efficacy and optimal dosage of sotalol on arrhythmia. Methods: 53 patients with non-myocardial infarction receiving sotalol with different string-does, were evaluated by clinic and 24-hour Holier monitoring. Results: (1) In all 53 patients, 39 cases were efficiency, the total effective rate was 73.58%. (2)In 39 efficacy cases, the average does was 93.57mg/d. (3)After oral low-does sotalol, QTc interval increased from (0.39±0.03) s to (0.41±0.03) s (0.01P0.05), HR decreased from (79.39±13.85) beats/min to (64.11 ± 8.19) beats/min(P0.01) But BP had no significant difference. (4) There were 9 cases had side effects, but all were alleviated by decreasing the dosage. No torsade de pointes. Conclusion: Sotalol was efficiency in treatment of supraventricular or ventricular arrhythmia.Its average efficient dose was low and its side effect was seldom. So it would become a better antiarrhythmic drug in future.
Key concepts: Sotalol, Medicine, Supraventricular arrhythmia, QT interval, Cardiology, Myocardial infarction, Anesthesia, Significant difference